High dose Ibandronate formulation

Details for Australian Patent Application No. 2003250218 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Kaestle, Hans-G.; Meyer, Bernard

Agent Spruson & Ferguson

Pub. Number AU-B-2003250218

PCT Number PCT/EP03/08732

PCT Pub. Number WO2004/056373

Priority 02028745.4 20.12.02 EP

Filing date 7 August 2003

Wipo publication date 14 July 2004

Acceptance publication date 26 October 2006

International Classifications

A61K 31/663 (2006.01)

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 02028745.4 20.12.02 EP

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2003250218

26 October 2006 Application Accepted

  Published as AU-B-2003250218

22 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003250219-METHOD FOR PRODUCING ALDEHYDES BY MEANS OF HYDROFORMYLATION OF OLEFINICALLY UNSATURATED COMPOUNDS, SAID HYDROFORMYLATION BEING CATALYSED BY UNMODIFIED METAL COMPLEXES IN THE PRESENCE OF CYCLIC CARBONIC ACID ESTERS

2003250217-GPI ANCHORED GLYCOPROTEIN ACA AS A NOVEL TUMOR MARKER